Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NYO3 is a premium dietary supplement brand headquartered in Norway, specializing in high-quality Antarctic krill oil and other marine-based nutraceuticals. The company focuses on the research, development, and commercialization of health products derived from pure Antarctic sources, utilizing advanced extraction technologies to maintain high concentrations of Omega-3 phospholipids and astaxanthin. NYO3 has established a significant global presence, particularly in the Asian and European markets, positioning itself as a leader in the 'pure and traceable' supplement sector. Their product portfolio extends beyond krill oil to include liver health supplements, probiotics, and specialized vitamins, all adhering to strict European quality standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NYO3.